People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BlueSphere Bio, Inc. | — | Biotech / Pharma | Series C | $55.6M | $1.5B | 2018 |
Mark Shlomchik at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Shlomchik on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeanne Cunicelli | 1 | 7 |
| David Apelian | 1 | 2 |
| Tal Heppenstall | 1 | 2 |
| Robert Lin | 1 | 2 |
| Alan Korman | 1 | 1 |
| Warren Shlomchik | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.